about
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approachesHypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesityNutritional lipidomics: molecular metabolism, analytics, and diagnosticsExposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse modelArsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- miceIn utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- miceSimvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering EffectLipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study.ApoE plasma levels and risk of cardiovascular mortality in old ageThyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort.Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases.FABP4 plasma levels are increased in familial combined hyperlipidemia.Influence on Adiposity and Atherogenic Lipaemia of Fatty Meals and Snacks in Daily Life.Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin.Lipoprotein particle concentrations in children and adults following Kawasaki disease.Are Additional Lipid Measures Useful?Birth weight, cord blood lipoprotein and apolipoprotein levels in Indian newborns.Associations between smoking, components of metabolic syndrome and lipoprotein particle size.IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosisHuman LDL structural diversity studied by IR spectroscopyThe effect of PPARgamma-agonism on LDL subclass profile in patients with type 2 diabetes and coronary artery disease.Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stressMetabolic syndrome: the danger signal in atherosclerosis.The Cognition and Affect after Stroke - a Prospective Evaluation of Risks (CASPER) study: rationale and design.Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.Plasma cytokine response during the postprandial period: a potential causal process in vascular disease?The impact of Roux-en-Y gastric bypass surgery on normal metabolism in a porcine modelTetranectin as a Potential Biomarker for Stable Coronary Artery Disease.Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic populationImplications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.Age and Sex Specific Reference Intervals for Modifiable Risk Factors of Cardiovascular Diseases for Gujarati Asian Indians.Early-stage atherosclerosis in poloxamer 407-induced hyperlipidemic mice: pathological features and changes in the lipid composition of serum lipoprotein fractions and subfractionsGenetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study.Dietary fats and health: dietary recommendations in the context of scientific evidenceLess subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort.Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes.
P2860
Q26866207-8909C1A7-261C-4108-B142-221275587ECDQ26992274-7057DACE-95A1-4C28-86D1-7EC6BFC1E6FCQ28390150-4CE6EE9A-EE81-457F-8EED-5E65E0655A8EQ28390580-C6CF61FD-5A20-424A-A8F2-C1C63C0FFC94Q28392848-42AD20AF-0A60-4A5C-9FA3-B22C483E8586Q28396600-D081ACFB-5BDA-466B-AB14-8D63B207588FQ28553042-266EA5FD-3F7C-476A-9A3B-2062278FD2DFQ30514016-33552AEB-3B4E-4444-A99D-53BA06D98024Q33242076-9BAA1AB0-265B-453E-85B0-6DDAC45C3FA0Q33309761-2A9F8BF1-689F-4803-95A8-D221AE8D983FQ33717612-B86852C6-4AC0-4D55-ADF2-EA7D50D4854FQ33784529-29B1781A-B008-44DA-BDDF-D7564AE3E01EQ33863703-E8A2F599-4948-476B-BBDC-CED678B82025Q34037325-D5ED72D5-4327-45D4-81A3-74A9D74E025EQ34390605-20B8EB62-4E3A-41CB-BB07-D06046DC2634Q34395917-97DD9CEE-FD90-410C-93DA-941588647E78Q34730419-2B525954-B1F7-484F-94E4-A59C29664C27Q34786468-A442EE89-463D-45FD-A68F-5FE5F025F3E5Q35042556-6EECCC9A-AB7A-4758-AB74-5B4C1D479575Q35070231-16F73E67-267F-4FA7-9C2F-A254C70A5C4FQ35124055-2264296F-D337-4208-AD8E-ACAEBFB769F8Q35612747-3ABF4092-D823-464C-8498-03AFF72586D2Q35776623-CD6F0620-4AC5-43C3-B32C-5578BEE78414Q35821951-9125705E-7931-461E-9255-8A6469FC7719Q35955745-004C007A-AA5B-4213-8A0E-ABC960AFA49DQ36012953-03DEE0EF-AC2C-4124-BE9F-574F1D4E2862Q36017124-B9890F52-A8AB-4BAB-ABC5-036B51312755Q36029202-C78176CE-DFD5-41FA-9A10-3513F3F9BCEEQ36037607-DA279E8F-E13A-48FA-A67A-A28119A768B0Q36296633-1BD1C43A-9709-4986-A014-66D1C16EC45BQ36333867-8BF97F50-A8CC-43F9-8447-85681B2745B5Q36353492-8A804730-D5E1-412B-89AA-14DC234CBDEAQ36384768-CB739164-2192-4E13-A550-4DDDF50DA88CQ36390892-AB89115D-0ACD-464E-B53E-FA97997B5C15Q36448461-F64135AA-A961-498B-8FB2-5637F447A7B6Q36493648-AF7EDAAF-1E44-4120-991A-0BC72F881BFBQ36697063-428EC409-1720-4EAE-B6AC-2DAFBC83EA6EQ36832940-0E8CA537-E850-4E38-BFF4-30E186A15E40Q36864835-107BCC6F-1AA1-4E89-B663-E1C2FDBD4131Q36926879-D36C9B4A-74A8-4279-94F2-5BAA9C1086D5
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Atherogenic lipoprotein particles in atherosclerosis
@ast
Atherogenic lipoprotein particles in atherosclerosis
@en
Atherogenic lipoprotein particles in atherosclerosis
@nl
type
label
Atherogenic lipoprotein particles in atherosclerosis
@ast
Atherogenic lipoprotein particles in atherosclerosis
@en
Atherogenic lipoprotein particles in atherosclerosis
@nl
prefLabel
Atherogenic lipoprotein particles in atherosclerosis
@ast
Atherogenic lipoprotein particles in atherosclerosis
@en
Atherogenic lipoprotein particles in atherosclerosis
@nl
P3181
P1433
P1476
Atherogenic lipoprotein particles in atherosclerosis
@en
P2093
Patrick Duriez
Rafael Carmena
P304
P3181
P356
10.1161/01.CIR.0000131511.50734.44
P407
P433
23 Suppl 1
P577
2004-06-15T00:00:00Z